{"id":"W4415941485","doi":"10.1016/j.annonc.2025.08.1705","title":"1065MO First-in-human study of AZD5335, a folate receptor α (FRα)-targeted antibody-drug conjugate, in patients with platinum-resistant recurrent ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Ovarian cancer; Conjugate; Folate receptor; Phases of clinical research; Topoisomerase; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007908511,0.0008172842,0.002005273,0.0004268841,0.0005010685,0.0008908359,0.0004182501,0.0009917709,0.001964201],"category_scores_gemma":[0.0007322542,0.0004186899,0.001324276,0.0003748226,0.0006867432,0.0005587086,0.0002574955,0.002019205,0.0005634922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008387032,"about_ca_system_score_gemma":0.0007392009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002143917,"about_ca_topic_score_gemma":0.002692476,"domain_scores_codex":[0.999584,0.0001687883,0.0000200544,0.00008403223,0.00003368289,0.0001094529],"domain_scores_gemma":[0.9996328,0.00007112123,0.00004769397,0.00004760781,0.00001936184,0.0001814591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6703487,0.05276699,0.06571107,0.0004843298,0.002374418,0.001939521,0.0007620726,0.003163666,0.06014738,0.0003687561,0.002236053,0.1396971],"study_design_scores_gemma":[0.06532418,0.8332872,0.07771052,0.00003591436,0.001480045,0.001152947,0.0001897398,0.002200782,0.01241366,0.0001386597,0.005998754,0.00006756896],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965755,0.00140307,0.0001859263,0.0001267486,0.00005025472,0.0002227622,0.0003221098,0.00003488969,0.001078717],"genre_scores_gemma":[0.997488,0.000549448,0.000176624,0.0001668284,0.00004791945,0.00008254439,0.0004802456,0.000009870977,0.0009985095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002143917,"threshold_uncertainty_score":0.006570935,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05104004993616807,"score_gpt":0.4325312644285181,"score_spread":0.38149121449235,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}